Use of KAI-1 as a prognostic factor in gastric carcinoma

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 12, 2009, Pages 1369-1372

  Ölhan, Özgür ^a   Çelik, Serkan Yaşar ^b   Han, Ünsal ^c   Önal, Binnur ^c  

^a Batman State Hospital   (Australia)

^b DIYARBAKIR MILITARY HOSPITAL   (Turkey)

^c MINISTRY OF HEALTH   (Turkey)

Author keywords

Gastric carcinoma; Immunohistochemistry; Kai 1; Prognosis

Indexed keywords

CD82 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA; STOMACH EPITHELIUM; STOMACH MUCOSA; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME;

CELL DIFFERENTIATION; FEMALE; GASTRIC MUCOSA; HUMANS; KANGAI-1 PROTEIN; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77950267938     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328323aac9     Document Type: Article

References (19)

1. Fenoglio-Preiser C, Carneiro F, Correa P, Guilford P, Lambert R, Megraud F, et al. WHO histological classification of gastric tumour. In: Hamilton SR, Aaltonen LA, editors. Tumours of the stomach in world health organization classification of tumours, pathology and genetics of tumours of the digestive system. Lyon, France: IARCH Press-Lyon; 2000. pp. 37-66. Chapter 3.
2. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003; 56:1-9.
3. Huang CL, Taki T, Adachi M, Yagita M, Savada S, Takabayashi A, et al. MRP-1/CD9 and KAI-1/CD82 expression in normal and various cancer tissues, Int J Oncol 1997; 11:1045-1051.
4. Takaoka A, Hinoda A, Salo S. Reduced invasive and metastatic potentials of KAI-1-transfected melanoma cells. Jpn J Cancer Res 1998; 89:397-404.
5. Yang XH, Welch DR, Phillips KK, Weissman BE, Wei LL KAI-I, a putative marker for metastatic potential in human breast cancer. Cancer Lett 1997; 119:149-155.
6. Su J, Arima K, Hasegawa M. Decreased expression of KAI-1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma, Int J Pathol 2004; 11:74-82.
7. Takada A, Hinoda Y, Satoh S, Adachi Y, ltoh F, Adachi M, Imai K. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI-I gene. Oncogene 1998; 16:1443-1453.
8. Lombardi DP, Geradts J, Foley JF. Loss of KAI-1 expression in the progression of colorectal cancer. Cancer Res 1999; 59:5724-5731.
9. Ueda T, Ichikawa T, Tamura J, Mikata A, Akakura K, Akimoto S et al. Expression of the KAI-1 protein in benign prostatic hyperplasia and prostate cancer. Am J Pathol 1996; 149:1435-1440.
10. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC. KAI-1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science (Washington DC) 1995; 268:884-886.
11. Guo X, Friess H, Graber HU, Kashiwagi M, Zimmermann A, Korc M, Buhler MW KAI-1 is up-regulated in early pancreatic cancer and decreased in the presence of metastasis. Cancer Res 1996; 56:4876-4880.
12. Lauren P. The two histological main types of gastric carcinoma; diffuse and so-called intestinal type carcinoma. Acta Pathol Microbiol Scand 1965; 64:31-49.
13. Bormann R. Tumors of Stomach and Duodenum. In: Henske F, Lubasch O, editors. Handbook of Specialized Pathologists in Anatomy and Histology. Berlin: Julius Springer-Berlin; 1926.
14. Grene FL Stomach in American Joint Committee on cancer-AJCC cancer staging manual. 6th ed. New York: Springer; 2002.
15. Allgayer H, Heiss MM, Schildberg FW. Prognostic factors in gastric cancer. Br J Surg 1997; 84:1651-1664.
16. Zheng HC, Wang MC, Li JY, Yang XF, Sun JM, Xin Y. Expression of maspin and kail and their clinicopathological significance in carcinogenesis and progression of gastric cancer. Chin Med Sci J 2004; 19:193-198.
17. Hinoda Y, Adachi Y,Takaoka A, Mitsuuchi H, Satoh Y, ltoh F, et al. Decreased expression of the metastasis suppressor gene KAI-1 in gastric cancer. Cancer Lett 1998; 129:229-234.
18. Tsutsumi S, Shimura T, Morinaga N, Mochiki E, Asao T, Kuwano H. Loss of KAI-1 expression in gastric cancer. Hepato-Gastroenterology 2005; 52:281-284.
19. Zheng H, Tsuneyama K, Cheng C, Takahashi H, Cui Z, Nomoto K, et al. Expression of KAH and tenascin, and microvessel density are closely correlated with liver metastasis of gastrointestinal adenocarcinoma. J Clin Pathol 2007; 60:50-56.